|
?:authorAffiliation
|
-
[\'Institute of Cardiovascular Sciences, University College London, London, UK; Barts Heart Centre, St Bartholomew\'s Hospital, Barts Health NHS Trust, London, UK.\', \'Barts Heart Centre, St Bartholomew\'s Hospital, Barts Health NHS Trust, London, UK.\', \'National Infection Service, Public Health England, Porton Down, UK.\', \'Division of Infection and Immunity, University College London, London, UK.\', \'Department of Virology, Barts Health NHS Trust, London, UK.\', \'Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.\', \'Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.\', \'MRC Unit for Lifelong Health and Ageing, University College London, London, UK; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Infection, Barts Health NHS Trust, London, UK.\', \'Royal Free London NHS Foundation Trust, London, UK; Division of Medicine, University College London, London, UK.\', \'Department of Immunology and Inflammation, Imperial College London, London, UK.\', \'Department of Infectious Disease, Imperial College London, London, UK.\', \'Division of Infection and Immunity, University College London, London, UK. Electronic address: m.noursadeghi@ucl.ac.uk.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}